LE WE PMID CA
Anticoagulants175Antikoagulantien

Anticoagulants (Coumarins Phenprocoumon Warfarin)

Anticoagulants

Apixaban

Atherosclerosis (BASKET)

Dabigatran

Endoscopy

Factor IX (Coagulation)

Factor VII (Coagulation)

Heart (Atrial fibrillation)

Heart valve (Artificial)

Osteocalcin

P selectin

Platelets (Therapeutic inhibitors)

Premedication and perioperative medicine

Rivaroxaban

Thrombosis (BASKET)

Tissue factor

1994  
1
Hereditary warfarin resistance.
[8134868] South Med J 87(3): 407-9 (1994)
2007  
2
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review.
[17846060] QJM 100(10): 599-607 (2007)
2002  
3
Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
[12096150] QJM 95(7): 451-9 (2002)
2006  
4
Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.
[16505257] Arch Intern Med 166(4): 391-7 (2006)
2005  
5
Systematic overview of warfarin and its drug and food interactions.
[15911722] Arch Intern Med 165(10): 1095-106 (2005)
1998  
6
Comparing different routes and doses of phytonadione for reversing excessive anticoagulation.
[9801181] Arch Intern Med 158(19): 2136-40 (1998)
2002  
7
Thrombin generation and its inhibition: a review of the scientific basis and mechanism of action of anticoagulant therapies.
[12173205] Br J Anaesth 88(6): 848-63 (2002)
2008  
8
Perioperative hemostatic management of patients treated with vitamin K antagonists.
[18946305] Anesthesiology 109(5): 918-26 (2008)
2009  
9
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy.
[20436891] Int J Emerg Med 2(4): 217-25 (2009)
2010  
10
Reversal of vitamin K antagonists prior to urgent surgery.
[20077167] Can J Anaesth 57(5): 458-67 (2010)
2006  
11
Perioperative management of patients receiving vitamin K antagonists.
[16766784] Can J Anaesth 53(6 Suppl): S113-22 (2006)
2010  
12
Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
[20718760] Cardiovasc Ther 28(5): 295-301 (2010)
2010  
13
New antithrombotics for atrial fibrillation.
[20645985] Cardiovasc Ther 28(5): 278-86 (2010)
2008  
14
Emergence of new oral antithrombotics: a critical appraisal of their clinical potential.
[19337550] Vasc Health Risk Manag 4(6): 1373-86 (2008)
2008  
15
Future innovations in anti-platelet therapies.
[18587441] Br J Pharmacol 154(5): 918-39 (2008)
2006  
16
2005  
17
New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin.
[15711585] Br J Pharmacol 144(8): 1017-28 (2005)
2008  
18
[Natural and synthetic glycosaminoglycans. Molecular characteristics as the basis of distinct drug profiles].
[18278163] Hamostaseologie 28(1-2): 51-61 (2008)
2005  
19
1997  
20
Correction of excessive anticoagulation with low-dose oral vitamin K1.
[9182473] Ann Intern Med 126(12): 959-62 (1997)
2008  
21
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents.
[18309033] Blood 111(10): 4871-9 (2008)
2008  
22
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based.
[18316627] Blood 111(9): 4471-6 (2008)
2005  
23
2008  
24
Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
[18574268] Chest 133(6 Suppl): 257S-298S (2008)
2008  
25
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
[18574265] Chest 133(6 Suppl): 160S-198S (2008)
1998  
26
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.
[9822057] Chest 114(5 Suppl): 445S-469S (1998)
2007  
27
Conundrums in the combined use of anticoagulants and antiplatelet drugs.
[17638939] Circulation 116(3): 305-15 (2007)
2008  
28
Vitamin K-dependent proteins, warfarin, and vascular calcification.
[18495950] Clin J Am Soc Nephrol 3(5): 1504-10 (2008)
2007  
29
Anticoagulants in heart disease: current status and perspectives.
[17426080] Eur Heart J 28(7): 880-913 (2007)
2006  
30
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.
[16143706] Eur Heart J 27(5): 519-26 (2006)
2008  
31
Management of excessive anticoagulant effect due to vitamin K antagonists.
[19074094] Hematology Am Soc Hematol Educ Program (): 266-70 (2008)
2008  
32
2004  
33
2001  
34
2008  
35
Perioperative management of warfarin therapy: to bridge or not to bridge, that is the question.
[18533078] Mayo Clin Proc 83(6): 628-9 (2008)
1989  
36
Long-term anticoagulation. Indications and management.
[2686173] West J Med 151(4): 414-29 (1989)
2008  
37
'Triple therapy' or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.
[18294567] J Am Coll Cardiol 51(8): 826-7 (2008)
2008  
38
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
[18294566] J Am Coll Cardiol 51(8): 818-25 (2008)
2003  
39
ABC of antithrombotic therapy: Antithrombotic therapy in special circumstances. II-In children, thrombophilia, and miscellaneous conditions.
[12521976] BMJ 326(7380): 93-6 (2003)
2009  
40
An algorithm for managing warfarin resistance.
[19952297] Cleve Clin J Med 76(12): 724-30 (2009)
2003  
41
When patients on warfarin need surgery.
[14650471] Cleve Clin J Med 70(11): 973-84 (2003)
2008  
42
Should patients on long-term warfarin take aspirin for heart disease?
[18383929] Cleve Clin J Med 75(3): 206-8 (2008)
2011  
43
Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review.
[21628615] Mayo Clin Proc 86(6): 509-21 (2011)
2010  
44
2004  
45
New anticoagulants for treatment of venous thromboembolism.
[15339877] Circulation 110(9 Suppl 1): I19-26 (2004)
2010  
46
Combination antithrombotic therapies.
[20124137] Circulation 121(4): 569-83 (2010)
2011  
47
Safety and efficacy of the oral direct factor xa inhibitor apixaban in Japanese patients with non-valvular atrial fibrillation. -The ARISTOTLE-J study-.
[21670542] Circ J 75(8): 1852-9 (2011)
2011  
48
Thrombin inhibitor or factor xa inhibitor? -Opening of a New Era of antithrombotic management-.
[21673455] Circ J 75(8): 1819-20 (2011)
2011  
49
Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents.
[21666370] Circ J 75(7): 1539-47 (2011)
2010  
50
Antithrombotic therapy. ESC guidelines vs JCS guidelines.
[21060203] Circ J 74(12): 2542-5 (2010)
2010  
51
Coagulation factor IXa as a target for treatment and prophylaxis of venous thromboembolism.
[20139356] Arterioscler Thromb Vasc Biol 30(3): 382-7 (2010)
2010  
52
Rivaroxaban: a new oral factor Xa inhibitor.
[20139357] Arterioscler Thromb Vasc Biol 30(3): 376-81 (2010)
2010  
53
Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin.
[20671233] Arterioscler Thromb Vasc Biol 30(10): 1885-9 (2010)
2007  
54
2009  
55
New antithrombotic agents: are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome?
[19491132] Eur Heart J 30(14): 1695-702 (2009)
2007  
56
Oral anticoagulant therapy. Fundamentals, clinical practice and recommendations.
[17939586] Rev Port Cardiol 26(7-8): 769-88 (2007)
2008  
57
The debate concerning oral anticoagulation: whether to suspend oral anticoagulants during dental treatment.
[18605071] Rev Port Cardiol 27(4): 531-44 (2008)
2010  
58
The new oral anticoagulants.
[19880491] Blood 115(1): 15-20 (2010)
2009  
59
Oral anticoagulation with Factor Xa and thrombin inhibitors: Is there an alternative to warfarin?
[20040270] Discov Med 8(43): 196-203 (2009)
2009  
60
Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice.
[19486503] Crit Care 13(2): 209 (2009)
2010  
61
Emergency reversal of warfarin anticoagulation.
[21078740] CMAJ 182(18): 2004 (2010)
2007  
62
What is the optimal level of anticoagulation in adult patients receiving warfarin following implantation of a mechanical prosthetic mitral valve?
[17669876] Interact Cardiovasc Thorac Surg 6(3): 390-6 (2007)
2010  
63
New options with dabigatran etexilate in anticoagulant therapy.
[20531953] Vasc Health Risk Manag 6(-): 339-49 (2010)
2010  
64
Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.
[20167958] Neth J Med 68(2): 68-76 (2010)
2010  
65
P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis.
[19962723] Thromb Res 125(4): e138-42 (2010)
2008  
66
Anticoagulants from hematophagous animals.
[21082917] Expert Rev Hematol 1(2): 135-9 (2008)
2011  
67
Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation.
[21305497] Cardiol J 18(1): 103-9 (2011)
2011  
68
Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention.
[21627469] Future Cardiol 7(3): 281-5 (2011)
2010  
69
The management of patients on dual antiplatelet therapy undergoing orthopedic surgery.
[21886534] HSS J 6(2): 182-9 (2010)
2011  
70
Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
[21547880] Endoscopy 43(5): 445-61 (2011)
2011  
71
Laboratory assessment of new anticoagulants.
[21288169] Clin Chem Lab Med 49(5): 761-72 (2011)
2010  
72
2010  
73
Correction of coagulopathy for percutaneous interventions.
[22550375] Semin Intervent Radiol 27(4): 338-47 (2010)
PMC   
74
Assessing bleeding risk in patients taking anticoagulants.
[23479259] J Thromb Thrombolysis 35(3):312-9 (2013)
PMC   
75
Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis.
[24505487] PLoS One 9(2):e88390 (2014)
PMC   
76
New oral anticoagulants: are coagulation units still required?
[24491189] Thromb J 12(1):3 (2014)
PMC   
77
New oral anticoagulants.
[23148053] CMAJ 185(4):E212 (2013)
PMC   
78
New Oral Anticoagulants for Atrial Fibrillation: Are They Worth the Risk?
[24672216] P T 39(1):54-64 (2014)
PMC   
79
Hokusai-VTE: Edoxaban for the treatment of venous thromboembolism.
[24749116] Glob Cardiol Sci Pract 2013(4):416-20 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



Search PubMed and many other databases on the combined search terms

GG: anticoagulant
GG: anticoagulants

  • Antikoagulantien

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia